Document is current
Any future updates will be listed below
-
Authors
Ho, Peh Joo
Ho, Weang Kee
Khng, Alexis J.
Yeoh, Yen Shing
Tan, Benita Kiat-Tee
Tan, Ern Yu
Lim, Geok Hoon
Tan, Su-Ming
Tan, Veronique Kiak Mien
Yip, Cheng-Har
Mohd-Taib, Nur-Aishah
Wong, Fuh Yong
Lim, Elaine Hsuen
Ngeow, Joanne
Chay, Wen Yee
Leong, Lester Chee Hao
Yong, Wei Sean
Seah, Chin Mui
Tang, Siau Wei
Ng, Celene Wei Qi
Yan, Zhiyan
Lee, Jung Ah
Rahmat, Kartini
Islam, Tania
Hassan, Tiara
Tai, Mei-Chee
Khor, Chiea Chuen
Yuan, Jian-Min
Koh, Woon-Puay
Sim, Xueling
Dunning, Alison M.
Bolla, Manjeet K.
Antoniou, Antonis C.
Teo, Soo-Hwang
Li, Jingmei http://orcid.org/0000-0001-8587-7511
Hartman, Mikael
- License Information
-
More Information
Article History
Received: 15 December 2021
Accepted: 14 March 2022
First Online: 26 April 2022
Declarations
:
: All studies were performed in accordance with the Declaration of Helsinki and all participants provided written informed consent. This study was approved by the institutional review board at the Agency for Science, Technology and Research (A-STAR) (ref: 2020-005). SGBCC was approved by the National Healthcare Group Domain Specific Review Board (reference number: 2017/00797) and the SingHealth Centralised Institutional Review Board (reference number: 2019/2246). MyBrCa was approved by the Independent Ethics Committee, Ramsay Sime Darby Health Care (reference number: 201109.4 and 201208.1), and the Medical Ethics Committee, University Malaya Medical Centre (reference number: 842.9).
: Not applicable.
: J.N receives research funding from AstraZeneca. The other authors declare that they have no potential competing interests.
